News Blow for Lilly after FDA panel uncertain over RA drug bariti... Doubts over marketability of drug if it is approved
News UK pharma calls for cooperation as EMA continues Brexit spli... Britain’s pharma trade body has issued a fresh Brexit warning, saying it would be disadvantageous to both the UK and the EU if drugs regulation diverges as a result of the political changes
News Pacira CEO hopes for further expansion to US nerve block lab... CEO wants "broad nerve block label" for Exparel
Events Partner Content 9th Annual Biologics Formulation Development and Drug Delive... Formulation development for Safe Delivery to patient
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
